## **International Cardiomyopathy Network (ICoN)** Trustees’ annual report and financial statements 1[st] January 2021 – 31[st] December 2021 Registered charity number: 1184472 International Cardiomyopathy Network Trustees’ annual report and financial statements 1[st] January – 31[st] December 2021 The trustees present their report with the financial statements of the charity for the period 1[st] January 2021 to 31st December 2021. The trustees have adopted the provisions of Accounting and Reporting by Charities; Statement of Recommended Practice applicable to charities preparing their accounts in accordance with the Financial Reporting Standard applicable in the UK and Republic of Ireland (FRS 102) (effective 1 January 2019) ## **Objectives and Activities** The objects of the charity as set out in its governing document are; - (1) To advance the education of healthcare professionals on the subject of cardiomyopathy and related diseases of the heart muscle through the provision of educational learning opportunities and other methods that trustees see fit so as to improve the detection and treatment of such diseases for the public benefit. - (2) To improve the health of people affected by cardiomyopathy and related diseases of the heart muscle through the promotion and facilitation of research for the public benefit in all aspects of cardiomyopathy and related diseases of the heart muscle by providing networking opportunities for researchers, support and advice to researchers and other means trustees see fit. - (3) To advance the education of healthcare professionals worldwide through the dissemination of the results of research into cardiomyopathy and related diseases of the heart muscle. - (4) To improve the health of people affected by cardiomyopathy and diseases of the heart muscle worldwide through the creation, monitoring and development of relevant guidance on the treatment of such diseases. - (5) To improve the health of people affected by cardiomyopathy worldwide through collaboration with relevant stakeholders in advocating for improved access to treatment for people affected by such diseases. - (6) To increase awareness of cardiomyopathy and related disorders among the general public and the support and information available to people with cardiomyopathy and related conditions. ## **Achievements and Performance** During the year, Trustees were able to start their programme of charitable activity and produced a series of online clinical “Heart Muscle Talks” providing easy to access learning opportunities for cardiologist and others with an interest in cardiomyopathy. Talks were recorded and are available on the charity’s website at www.cardiomyopathy-icon.org Trustees had originally expected to begin their policy development and strategic planning activity in 2021. By the start of the year, however, it had become clear that plans for this activity would still be delayed by the COVID-19 pandemic, especially as all trustees and the intended beneficiaries of activity hold front line roles in the NHS and other European health services. International Cardiomyopathy Network Trustees’ annual report and financial statements 1[st] January – 31[st] December 2021 Trustees did continue to meet throughout the period to develop plans with these regular meetings also providing a valuable forum for trustees, who represent leading experts in cardiomyopathy throughout Europe, to discuss the impact of the pandemic on people with cardiomyopathy and how different health systems were coping with the needs of cardiomyopathy patients. ## Future Plans Trustees are confident that as the impact of the pandemic eases, they will be able to begin the work of developing national and international health policy positions as well as formalising the organisations long-term strategic plan. ## **Financial Review** There was no income or expenditure recorded during the reporting period. Since this reporting period, Trustees have been able to secure the support of a number of sponsors from the pharmaceutical industry. Trustees expect that income received in 2022 will be around £100,000. ## **Structure, Governance and Management** The charity is registered as a charitable incorporated organisation (CIO). The members of the CIO are its charity trustees. The only persons eligible to be members of the CIO are its charity trustees. Membership of the CIO cannot be transferred to anyone else. Any member and charity trustee who ceases to be a charity trustee automatically ceases to be a member of the CIO. Apart from the first charity trustees, every trustee must be appointed for a term of 3 years by a resolution passed at a properly convened meeting of the charity trustees. In selecting individuals for appointment as charity trustees, the charity trustees must have regard to the skills, knowledge and experience needed for the effective administration of the CIO. ## **Reference and Administrative details** International Cardiomyopathy Network (ICoN) Registered charity number: 1184472 Correspondence address C/O Cardiomyopathy UK 75a Woodside Road Amersham Buckinghamshire HP6 6AA International Cardiomyopathy Network Trustees’ annual report and financial statements 1[st] January – 31[st] December 2021 ## Trustees Prof. Perry Elliott (UK) - Chair Appointed July 2019 Dr Aris Anastasakis (Greece) Appointed July 2019 Prof. Eloisa Arbustini (Italy) Appointed July 2019 Prof. Iacopo Olivotto (Italy) Appointed July 2019 Dr Juan Pablo Kaski (UK) Appointed July 2019 Dr Juan Ramon Gimeno Blanes (Spain) Appointed July 2019 Prof. Lucie Carrier (Germany) Appointed July 2019 Professor Jolanda van der Velden (Netherlands) Appointed April 2021 Prof. Claudio Rapezzi (Italy) Appointed November 2021 Prof. Ales Linhart (Chech Republic) Appointed July 2019 ## **Declarations** The Trustees declare that they have approved the trustees’ report above. Signed on behalf of the charity’s trustees Prof. Perry Elliott, Chair of Trustees 31[st] August 2022 ||**International Cardiomyopathy Network**|**International Cardiomyopathy Network**|**International Cardiomyopathy Network**|**1184472**|**1184472**|**1184472**|**CC16a**| |---|---|---|---|---|---|---|---| ||**For the period**
**from**|01/01/2021|**To**||31/12/2021||| ||||||||| |**Section A Receipts and payments**|||||||| |**A1 Receipts**|**Unrestricted**
**funds**
**to the nearest £**
**0**
**0**
**0**
**0**

**0**
**0**
**0**
**0**
**0**
**0**
**0**
**0**
**0**
**0**
**0**
**0**
**0**|**Restricted**
**funds**
**to the nearest £**
**0**
**0**
**0**
**0**
**0**
**0**
**0**
**0**
**0**
**0**
**0**
**0**
**0**
**0**
**0**
**0**
**0**|**Endowment**
**funds**
**to the nearest £**
**0**
**0**
**0**
**0**
**0**
**0**
**0**
**0**
**0**
**0**
**0**
**0**
**0**
**0**
**0**
**0**
**0**||**Total funds**
**to the nearest £**
**0**
**0**
**0**||**Last year**
**to the nearest £**| |Grants and Donations|**0**||||||**N/A**| |Charitable activity|**0**||||||**N/A**| |**_Sub total_**_(Gross income for AR)_|**0**||||||**N/A**| ||||||||| |**A2 Asset and investment sales, (see**
**table).**|||||||| ||**0**||||**0**||**N/A**| |**_Sub total_**|
**0**||||**0**||**N/A**| |**_Total receipts_**
**A3 Payments**|||||||| ||||||||**N/A**| ||||||||| |
Fundraising|**0**||||||**N/A**| |Charitable activity|**0**||||||**N/A**| |Overheads and Administration|**0**||||||**N/A**| |**_Sub total_**|**0**||||||**N/A**| ||||||||| |**A4 Asset and investment purchases,**
**(see table)**|||||||| ||**0**||||**0**||**N/A**| |**_Sub total_**|**0**||||**0**||**N/A**| |**_Total payments_**
**_Net of receipts/(payments)_**
**A5 Transfers between funds**
**A6 Cash funds last year end**
**_Cash funds this year end_**|||||||| ||||||||**N/A**| ||||||||| ||**0**|**0**|**0**||**0**||**N/A**| ||**0**|**0**|**0**||**0**||**N/A**| ||**0**|**0**|**0**||**0**||**N/A**| ||**0**|**0**|**0**||**0**||**N/A**| CCXX R1 accounts (SS) 31/08/2022 1 |**Section B Statement of assets and liabilities at the end of the period**|**Section B Statement of assets and liabilities at the end of the period**|**Section B Statement of assets and liabilities at the end of the period**|| |---|---|---|---| |**Categories**
Signed by one or two trustees on behalf of all
the trustees
**B5 Liabilities**
**B3 Investment assets**
**B2 Other monetary assets**
**B4 Assets retained for the charity’s**
**own use**
**B1 Cash funds**|**Details**
**Details**
**_Total cash funds_**
(agree balances with receipts and payments
account(s))
**Details**
**Details**
**Details**
Signature|**Unrestricted**
**funds**
**Restricted**
**funds**
**to nearest £**
**to nearest £**
**0**
**0**
**0**
**0**
**0**
**0**
**0**
**0**
OK
OK
**Unrestricted**
**funds**
**Restricted**
**funds**
**to nearest £**
**to nearest £**
**0**
**0**
**0**
**0**
**0**
**0**
**0**
**0**
**0**
**0**
**0**
**0**
**Fund to which**
**asset belongs**
**Cost (optional)**
**0**
**0**
**0**
**0**
**0**
**Fund to which**
**asset belongs**
**Cost (optional)**
**0**
**0**
**0**
**0**
**0**
**0**
**0**
**0**
**0**
**Fund to which**
**liability relates**
**Amount due**
**(optional)**
**0**
**0**
**0**
**0**
**0**
Print Name
Prof. PerryElliott|**Endowment**
**funds**
**to nearest £**| ||||**0**| ||||**0**| ||||**0**| ||||**0**| ||||OK| ||||**Endowment**
**funds**
**to nearest £**| ||||**0**| ||||**0**| ||||**0**| ||||**0**| ||||**0**| ||||**0**| ||||**Current value**
**(optional)**| ||||**0**| ||||**0**| ||||**0**| ||||**0**| ||||**0**| ||||**Current value**
**(optional)**| ||||**0**| ||||**0**| ||||**0**| ||||**0**| ||||**0**| ||||**0**| ||||**0**| ||||**0**| ||||**0**| ||||**When due**
**(optional)**| ||||| ||||| ||||| ||||| ||||| ||||| ||||Date of
approval| |||Prof. PerryElliott|31.08.2022| ||||| CCXX R2 accounts (SS) 31/08/2022 2